Global Thin Film Drugs Market Growth (Status and Outlook) 2023-2029

Global Thin Film Drugs Market Growth (Status and Outlook) 2023-2029

Product Code:450292

Published Date: Feb 08,2023

Pages: 120

Region: Global

Category: Medical Care

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.

LPI (LP Information)' newest research report, the “Thin Film Drugs Industry Forecast” looks at past sales and reviews total world Thin Film Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Thin Film Drugs sales for 2023 through 2029. With Thin Film Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Thin Film Drugs industry.

This Insight Report provides a comprehensive analysis of the global Thin Film Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Thin Film Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Thin Film Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Thin Film Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Thin Film Drugs.

The global Thin Film Drugs market size is projected to grow from US$ 7541.3 million in 2022 to US$ 14180 million in 2029; it is expected to grow at a CAGR of 9.4% from 2023 to 2029.

Global Thin Film Drugs key players include GSK, LTS, J&J, Indivior, Pfizer, etc. Global top five manufacturers hold a share over 35%.

Europe is the largest market, with a share about 40%, followed by Asia-Pacific, and North America, both have a share about 45 percent. 
In terms of product, Transdermal Film is the largest segment, with a share over 70%. And in terms of application, the largest application is Drugstores, followed by Hospitals, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Thin Film Drugs market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
    Transdermal Film
    Oral Thin Film
    Others

Segmentation by application
    Hospitals
    Drugstores
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    GSK
    LTS
    J&J
    Indivior
    Pfizer
    Sanofi
    Church & Dwight
    tesa Labtec
    Tapemark
    Prestige Bands
    Sun Pharma
    MonoSol
    BioDelivery
    Arx
    ZIM
    NAL Pharma
    AdhexPharma
    Aavishkar
    IntelGenx Corp
    APR